EU Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy

CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy

If approved by the European Commission, Duvyzat will be available for individuals with DMD aged six years and older who are able to walk.